"Open Rank"

The Division of Hematology and the UNC Blood Research Center at the University of North Carolina at Chapel Hill are seeking to recruit a physician-scientist with a focus in benign/classical hematology at the academic rank of Associate Professor or Professor. The UNC School of Medicine receives >$620M in research funding annually, placing it in the top 5 public medical schools for NIH funding. All of the Basic Science Departments are ranked in the top 10 for NIH funding, while 11 of the clinical departments are ranked in the top 25 for NIH funding.

Successful candidates will have an established track record of high-quality peer-reviewed publications and external funding in clinical or bench/translational research. Disease areas of interest include (but are not limited to) thrombosis and hemostasis, sickle cell disease and other hemoglobinopathies, hereditary hemorrhagic telangiectasia, or hematopoiesis/iron metabolism. The Division of Hematology faculty currently includes 8 practicing physician-scientists and 6 PhD scientists. There are several large well-established lifespan disorders programs that closely collaborate with colleagues in pediatric hematology-oncology to manage transition to adult clinics in sickle cell disease, bleeding disorders, and HHT. All clinics are conducted in the recently constructed, purpose-built Eastowne facility that also houses a dedicated clinical research unit.

The UNC Blood Research Center is comprised of 35 investigators with a variety of clinical and basic research interests. In addition to the Department of Medicine, members hold primary faculty appointments in Pediatrics, Pathology and Laboratory Medicine, Biochemistry and Biophysics, and Biomedical Engineering. Twelve core members occupy 1500 ft2 of contiguous lab and office space, and together account for $5.5M of extra-mural funding. Additional research collaborations exist with the highly ranked Gillings School of Public Health and Eshelman School of Pharmacy. For over 70 years, the Francis Owen Blood Research Laboratory has functioned as a national resource, housing large animal models of hemophilia and other bleeding disorders that have been critical to the development of novel protein and gene therapies in bleeding disorders. Finally, a long-standing NIH postdoctoral T32 training grant supports 5 MD or PhD trainees focused on benign hematologic disorders.

Academic rank will be commensurate with the candidate's experience and accomplishments. The successful candidate will be expected to meet UNC criteria to be appointed on the tenure track.